Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's ...

In the early 1900s, Swedish physician Henrik Sjögren (SHOW-gren) first described a group of women whose chronic arthritis was ...

Reported as titer. Present in 30% (Ro/SS-A) and 15% (La/SS-B) of patients with SLE. These antibodies are also seen in patients with Sjogren's syndrome. Anti-Ro/SS-A alone is more common in SLE ...

Johnson & Johnson’s ‘Swiss army knife’ for autoimmune diseases – FcRn inhibitor nipocalimab – has shown efficacy in Sjogren ... arthritis, systemic lupus erythematosus (SLE), idiopathic ...

In transgenic mice, over-production of this one molecule yields clinical symptoms that are very similar to those seen in human SLE and Sjogren's syndrome,” explains Fabienne Mackay, Professor of ...

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome.